Following the Bacillus Calmette-Guérin shortage, the first patient with bladder cancer has been dosed with recombinant ...

Dr. Desai will be recognized at the American Urological Association's Annual Meeting in Las Vegas, Nevada, in April 2025.

A live webcast of the event, as well as an archived recording, will be available on the “Investors” section of the Company’s website at https://ir.procept-biorobotics.com/. The webcast will be ...

Sexual function data support enzalutamide use in men with high-risk biochemically recurrent (BCR) prostate cancer.

Prostate cancer remains one of the most commonly diagnosed cancersworldwide, with 1.4 million new cases and over 375,000 ...

Findings in patients with interstitial cystitis/bladder pain syndrome can help with diagnosis of interstitial cystitis subtypes ...

March 19 marks Certified Nurses Day™, a day dedicated to recognizing nurses who have achieved the highest standards of professionalism and excellence through specialty certification. The Certification ...

Urology of Virginia, a globally recognized leader in urologic care, is reinventing patient education and clinic efficiency ...

U.S. Urology Partners is one of the first providers to offer patients ImmunityBio’s recombinant Bacillus Calmette-Guérin (rBCG) The FDA recently authorized ImmunityBio’s EAP for rBCG to address U.S.

The Department of Urology residency program is a five year program consisting of a preliminary year followed by four years of urology. Our preliminary year provides an introduction to urology and ...

The Scott Department of Urology leadership and residents hosted a virtual open house to introduce prospective applicants to the department's residency program. The open house featured details about ...